We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BCYC icon
201
Bicycle Therapeutics
BCYC
$272M
$1.76M 0.05%
87,060
+2,080
+2% +$47K
2022 Q1
9 quarters
BPMC icon
202
DELISTED
Blueprint Medicines
BPMC
$1.76M 0.05%
16,343
-1,657
-9% -$166K
2022 Q4
6 quarters
CSLM icon
203
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$1.76M 0.05%
156,317
– –
2022 Q1
9 quarters
ADT icon
204
ADT
ADT
$4.7B
$1.75M 0.05%
229,607
– –
2018 Q2
24 quarters
PD icon
205
PagerDuty
PD
$1.27B
$1.72M 0.05%
75,000
+45,000
+150% +$938K
2024 Q1
1 quarter
BKD icon
206
Brookdale Senior Living
BKD
$2.42B
$1.72M 0.05%
251,535
+142,535
+131% +$964K
2023 Q4
2 quarters
PLD icon
207
Prologis
PLD
$123B
$1.72M 0.05%
+15,279
New +$1.69M
2024 Q2
0 quarters
ADI icon
208
Analog Devices
ADI
$197B
$1.71M 0.05%
+7,500
New +$1.6M
2024 Q2
0 quarters
ITUB icon
209
Itaú Unibanco
ITUB
$112B
$1.71M 0.05%
+330,871
New +$1.81M
2024 Q2
0 quarters
CARG icon
210
CarGurus
CARG
$2.57B
$1.7M 0.05%
65,000
+40,000
+160% +$952K
2024 Q1
1 quarter
AOGO icon
211
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$1.7M 0.05%
156,317
– –
2022 Q2
8 quarters
DXCM icon
212
DexCom
DXCM
$31.7B
$1.7M 0.05%
+15,000
New +$1.9M
2024 Q2
0 quarters
ZG icon
213
Zillow
ZG
$6.72B
$1.69M 0.05%
37,500
-15,000
-29% -$647K
2023 Q4
2 quarters
VEEA
214
Veea Inc
VEEA
$17.7M
$1.67M 0.05%
7,972
– –
2021 Q2
12 quarters
INCY icon
215
Incyte
INCY
$22.9B
$1.67M 0.05%
27,550
+11,300
+70% +$640K
2023 Q1
5 quarters
DESP icon
216
DELISTED
Despegar.com
DESP
$1.65M 0.05%
+125,000
New +$1.65M
2024 Q2
0 quarters
OCUL icon
217
Ocular Therapeutix
OCUL
$1.66B
$1.63M 0.05%
238,659
+50,081
+27% +$309K
2022 Q1
9 quarters
FNVT icon
218
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$1.63M 0.05%
143,494
– –
2021 Q4
10 quarters
LRCX icon
219
Lam Research
LRCX
$399B
$1.6M 0.05%
+15,000
New +$1.44M
2024 Q2
0 quarters
DOC icon
220
Healthpeak Properties
DOC
$13B
$1.59M 0.04%
81,046
+13,846
+21% +$264K
2023 Q2
4 quarters
GTY icon
221
Getty Realty Corp
GTY
$1.73B
$1.56M 0.04%
58,428
+48,298
+477% +$1.31M
2023 Q1
5 quarters
M icon
222
Macy's
M
$5.92B
$1.55M 0.04%
+80,801
New +$1.54M
2024 Q2
0 quarters
EWTX icon
223
Edgewise Therapeutics
EWTX
$4.24B
$1.53M 0.04%
85,008
+9,911
+13% +$173K
2022 Q2
8 quarters
LRMR icon
224
Larimar Therapeutics
LRMR
$277M
$1.51M 0.04%
207,783
+5,000
+2% +$38.3K
2022 Q4
6 quarters
TER icon
225
Teradyne
TER
$63B
$1.48M 0.04%
+10,000
New +$1.27M
2024 Q2
0 quarters
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.